Nasopharyngeal necrosis contributes to overall survival in nasopharyngeal carcinoma without distant metastasis: a comprehensive nomogram model

[1] Wei WI(2005)Nasopharyngeal carcinoma Lancet 365 2041-2054

[2] Sham JS(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424

[3] Bray F(2019)Nasopharyngeal carcinoma Lancet 394 64-80

[4] Ferlay J(2015)Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: a 10-year experience with a large cohort and long follow-up Eur J Cancer 51 2587-2595

[5] Soerjomataram I(2019)The association between the development of radiation therapy, image technology, and chemotherapy, and the survival of patients with nasopharyngeal carcinoma: a cohort study from 1990 to 2012 Int J Radiat Oncol Biol Phys 105 581-590

[6] Siegel RL(2016)Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial Lancet Oncol 17 1509-1520

[7] Torre LA(2019)Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma N Engl J Med 381 1124-1135

[8] Jemal A(2000)Endoscopic management of skull base osteoradionecrosis Laryngoscope 110 1162-1165

[9] Chen YP(2006)Diagnosis and management of skull base osteoradionecrosis after radiotherapy for nasopharyngeal carcinoma Laryngoscope 116 1626-1631

[10] Chan ATC(2016)A model to predict the risk of lethal nasopharyngeal necrosis after re-irradiation with intensity-modulated radiotherapy in nasopharyngeal carcinoma patients Chin J Cancer 35 59-538

[1] Wei WI(2005)Nasopharyngeal carcinoma Lancet 365 2041-2054

[2] Sham JS(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424

[3] Bray F(2019)Nasopharyngeal carcinoma Lancet 394 64-80

[4] Ferlay J(2015)Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: a 10-year experience with a large cohort and long follow-up Eur J Cancer 51 2587-2595

[5] Soerjomataram I(2019)The association between the development of radiation therapy, image technology, and chemotherapy, and the survival of patients with nasopharyngeal carcinoma: a cohort study from 1990 to 2012 Int J Radiat Oncol Biol Phys 105 581-590

[6] Siegel RL(2016)Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial Lancet Oncol 17 1509-1520

[7] Torre LA(2019)Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma N Engl J Med 381 1124-1135

[8] Jemal A(2000)Endoscopic management of skull base osteoradionecrosis Laryngoscope 110 1162-1165

[9] Chen YP(2006)Diagnosis and management of skull base osteoradionecrosis after radiotherapy for nasopharyngeal carcinoma Laryngoscope 116 1626-1631

[10] Chan ATC(2016)A model to predict the risk of lethal nasopharyngeal necrosis after re-irradiation with intensity-modulated radiotherapy in nasopharyngeal carcinoma patients Chin J Cancer 35 59-538